Researchers in the U.K. who previously showed GSK plc’s Shingrix is associated with a lower risk of dementia have now extended their findings to link the recombinant shingles vaccine to a lower risk of cardiovascular disease.
Fresh evidence GSK’s shingles vaccine reduces cardiovascular risk
